And both companies are funding highly potential phase 3 trials after very exciting phase 2 results.
Acl have been fumbling the ball, with investor expectations.
POH have really put a lot of hard work in, to fix this area. Where they were weak.
Perception is everything here.
As Kwaidan has previously posted doe ACL have any market savvy executives.
POH brought one in to fix their problem.
ACL could copy this strategy.
And both companies are funding highly potential phase 3 trials...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable